Can a simple eye drop slow down worsening nearsightedness in kids?

NCT ID NCT07329777

Recruiting now Disease control Sponsor: IDB VisionCare SDN BHD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether low-dose atropine eye drops (0.025%) can safely slow the progression of myopia (nearsightedness) in children aged 5 to 10. Over two years, 144 children will receive either the active drops or a placebo. The goal is to see if the drops reduce how quickly their eyesight gets worse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-dose atropine sulfate eye drops (0.025%)
What this could lead to: If it works, this could provide a safe, daily eye drop option to slow down worsening nearsightedness in children, reducing the need for stronger glasses later.
What could go wrong: This is a relatively small, early-phase trial (144 children) and the effect may be modest. Atropine can cause light sensitivity or blurry near vision, and long-term safety beyond 2 years is not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA PROGRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA PROGRESSION

Contacts and locations

Locations

Hospital Pakar Kanak-Kanak UKM
RECRUITING

Kuala Lumpur, Cheras, 56000, Malaysia
Universiti Malaya Medical Centre
RECRUITING

Kuala Lumpur, Petaling Jaya, 50603, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.